vs
UiPath, Inc.(PATH)与Pennant Group, Inc.(PNTG)财务数据对比。点击上方公司名可切换其他公司
UiPath, Inc.的季度营收约是Pennant Group, Inc.的1.4倍($411.1M vs $289.3M),UiPath, Inc.净利率更高(48.4% vs 3.0%,领先45.4%),Pennant Group, Inc.同比增速更快(53.2% vs 15.9%),UiPath, Inc.自由现金流更多($25.1M vs $17.4M),过去两年Pennant Group, Inc.的营收复合增速更高(35.8% vs 0.7%)
UiPath是一家全球化软件企业,专注于开发人工智能、智能自动化及流程编排类软件,其产品支持用户搭建与调度AI代理,实现复杂业务流程、工作流的自动化运行,助力各行业客户提升运营效率、降低人力成本。
Pennant Group, Inc.是一家总部位于美国的医疗服务企业,主营家庭健康护理、临终关怀、长者居住服务及专业护理服务,业务覆盖美国数十个州,核心服务对象为老年及有特殊医疗需求的弱势人群。
PATH vs PNTG — 直观对比
营收规模更大
PATH
是对方的1.4倍
$289.3M
营收增速更快
PNTG
高出37.2%
15.9%
净利率更高
PATH
高出45.4%
3.0%
自由现金流更多
PATH
多$7.7M
$17.4M
两年增速更快
PNTG
近两年复合增速
0.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $411.1M | $289.3M |
| 净利润 | $198.8M | $8.6M |
| 毛利率 | 83.3% | — |
| 营业利润率 | 3.2% | 6.0% |
| 净利率 | 48.4% | 3.0% |
| 营收同比 | 15.9% | 53.2% |
| 净利润同比 | 1966.2% | 50.0% |
| 每股收益(稀释后) | $0.37 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PATH
PNTG
| Q4 25 | $411.1M | $289.3M | ||
| Q3 25 | $361.7M | $229.0M | ||
| Q2 25 | $356.6M | $219.5M | ||
| Q1 25 | $423.6M | $209.8M | ||
| Q4 24 | $354.7M | $188.9M | ||
| Q3 24 | $316.3M | $180.7M | ||
| Q2 24 | $335.1M | $168.7M | ||
| Q1 24 | $405.3M | $156.9M |
净利润
PATH
PNTG
| Q4 25 | $198.8M | $8.6M | ||
| Q3 25 | $1.6M | $6.1M | ||
| Q2 25 | $-22.6M | $7.1M | ||
| Q1 25 | $51.8M | $7.8M | ||
| Q4 24 | $-10.7M | $5.8M | ||
| Q3 24 | $-86.1M | $6.2M | ||
| Q2 24 | $-28.7M | $5.7M | ||
| Q1 24 | $33.9M | $4.9M |
毛利率
PATH
PNTG
| Q4 25 | 83.3% | — | ||
| Q3 25 | 82.2% | — | ||
| Q2 25 | 82.1% | — | ||
| Q1 25 | 84.8% | — | ||
| Q4 24 | 82.0% | — | ||
| Q3 24 | 80.0% | — | ||
| Q2 24 | 83.5% | — | ||
| Q1 24 | 86.8% | — |
营业利润率
PATH
PNTG
| Q4 25 | 3.2% | 6.0% | ||
| Q3 25 | -5.6% | 4.5% | ||
| Q2 25 | -4.6% | 5.3% | ||
| Q1 25 | 7.9% | 6.0% | ||
| Q4 24 | -12.2% | 4.9% | ||
| Q3 24 | -32.7% | 6.0% | ||
| Q2 24 | -14.8% | 5.7% | ||
| Q1 24 | 3.7% | 5.4% |
净利率
PATH
PNTG
| Q4 25 | 48.4% | 3.0% | ||
| Q3 25 | 0.4% | 2.7% | ||
| Q2 25 | -6.3% | 3.2% | ||
| Q1 25 | 12.2% | 3.7% | ||
| Q4 24 | -3.0% | 3.0% | ||
| Q3 24 | -27.2% | 3.4% | ||
| Q2 24 | -8.6% | 3.4% | ||
| Q1 24 | 8.4% | 3.1% |
每股收益(稀释后)
PATH
PNTG
| Q4 25 | $0.37 | $0.25 | ||
| Q3 25 | $0.00 | $0.17 | ||
| Q2 25 | $-0.04 | $0.20 | ||
| Q1 25 | $0.09 | $0.22 | ||
| Q4 24 | $-0.02 | $0.16 | ||
| Q3 24 | $-0.15 | $0.20 | ||
| Q2 24 | $-0.05 | $0.18 | ||
| Q1 24 | $0.07 | $0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | — |
| 总债务越低越好 | — | $168.8M |
| 股东权益账面价值 | $1.9B | $374.3M |
| 总资产 | $2.9B | $968.2M |
| 负债/权益比越低杠杆越低 | — | 0.45× |
8季度趋势,按日历期对齐
现金及短期投资
PATH
PNTG
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.9B | — |
总债务
PATH
PNTG
| Q4 25 | — | $168.8M | ||
| Q3 25 | — | $26.0M | ||
| Q2 25 | — | $37.0M | ||
| Q1 25 | — | $52.5M | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $108.9M | ||
| Q2 24 | — | $82.2M | ||
| Q1 24 | — | $83.3M |
股东权益
PATH
PNTG
| Q4 25 | $1.9B | $374.3M | ||
| Q3 25 | $1.7B | $343.0M | ||
| Q2 25 | $1.7B | $333.6M | ||
| Q1 25 | $1.8B | $323.0M | ||
| Q4 24 | $1.7B | $312.0M | ||
| Q3 24 | $1.8B | $187.3M | ||
| Q2 24 | $2.0B | $173.0M | ||
| Q1 24 | $2.0B | $164.2M |
总资产
PATH
PNTG
| Q4 25 | $2.9B | $968.2M | ||
| Q3 25 | $2.6B | $753.6M | ||
| Q2 25 | $2.6B | $751.4M | ||
| Q1 25 | $2.9B | $743.6M | ||
| Q4 24 | $2.7B | $679.5M | ||
| Q3 24 | $2.7B | $646.8M | ||
| Q2 24 | $2.8B | $602.5M | ||
| Q1 24 | $3.0B | $578.2M |
负债/权益比
PATH
PNTG
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.48× | ||
| Q1 24 | — | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $28.3M | $21.0M |
| 自由现金流经营现金流 - 资本支出 | $25.1M | $17.4M |
| 自由现金流率自由现金流/营收 | 6.1% | 6.0% |
| 资本支出强度资本支出/营收 | 0.8% | 1.2% |
| 现金转化率经营现金流/净利润 | 0.14× | 2.43× |
| 过去12个月自由现金流最近4个季度 | — | $36.3M |
8季度趋势,按日历期对齐
经营现金流
PATH
PNTG
| Q4 25 | $28.3M | $21.0M | ||
| Q3 25 | $41.6M | $13.9M | ||
| Q2 25 | $119.0M | $34.6M | ||
| Q1 25 | $146.1M | $-21.2M | ||
| Q4 24 | $28.1M | $20.6M | ||
| Q3 24 | $46.4M | $7.7M | ||
| Q2 24 | $100.0M | $10.5M | ||
| Q1 24 | $145.6M | $545.0K |
自由现金流
PATH
PNTG
| Q4 25 | $25.1M | $17.4M | ||
| Q3 25 | — | $10.5M | ||
| Q2 25 | $106.2M | $31.6M | ||
| Q1 25 | $138.7M | $-23.2M | ||
| Q4 24 | $23.2M | $17.2M | ||
| Q3 24 | $45.0M | $6.8M | ||
| Q2 24 | $98.8M | $8.9M | ||
| Q1 24 | $141.8M | $-2.6M |
自由现金流率
PATH
PNTG
| Q4 25 | 6.1% | 6.0% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | 29.8% | 14.4% | ||
| Q1 25 | 32.7% | -11.1% | ||
| Q4 24 | 6.5% | 9.1% | ||
| Q3 24 | 14.2% | 3.8% | ||
| Q2 24 | 29.5% | 5.3% | ||
| Q1 24 | 35.0% | -1.7% |
资本支出强度
PATH
PNTG
| Q4 25 | 0.8% | 1.2% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 3.6% | 1.4% | ||
| Q1 25 | 1.7% | 0.9% | ||
| Q4 24 | 1.4% | 1.8% | ||
| Q3 24 | 0.4% | 0.5% | ||
| Q2 24 | 0.4% | 1.0% | ||
| Q1 24 | 0.9% | 2.0% |
现金转化率
PATH
PNTG
| Q4 25 | 0.14× | 2.43× | ||
| Q3 25 | 26.25× | 2.29× | ||
| Q2 25 | — | 4.89× | ||
| Q1 25 | 2.82× | -2.73× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.84× | ||
| Q1 24 | 4.29× | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
PNTG
| Home Health Subsegment | $136.2M | 47% |
| Hospice Subsegment | $97.1M | 34% |
| Private And Other | $36.4M | 13% |
| Medicare And Medicaid | $19.6M | 7% |
| Affiliated Entity | $2.2M | 1% |